Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy
- 1 December 1998
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 22 (3) , 201-213
- https://doi.org/10.1016/s0169-5002(98)00089-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.Journal of Clinical Oncology, 1998
- Revisions in the International System for Staging Lung CancerChest, 1997
- Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.Journal of Clinical Oncology, 1995
- Prognostic factors in lung cancer: tables and commentsEuropean Respiratory Journal, 1994
- Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancerCancer, 1993
- Staging Systems of Lung CancerMayo Clinic Proceedings, 1993
- Comparison of the radiation therapy oncology group and american joint committee on cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the radiation therapy oncology group protocol 83-11Cancer, 1991
- Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small-cell lung cancer treated with radiation therapy.Journal of Clinical Oncology, 1990
- A New International Staging System for Lung CancerChest, 1986
- A new international staging system for lung cancerChest, 1986